LFCR News and Press, Lifecore Biomedical Inc.

CHASKA, Minn., March 10, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:  LFCR ) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that the company will participate in the up...

CHASKA, Minn., March 09, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:  LFCR ) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that it will report financial results for the fo...

Indomo Developing Fast-Acting, At-Home Treatment for Inflammatory Acne Lesions to be Administered with the ClearPen ™ , its Proprietary Intradermal Self-Injection Device Lifecore to Manufacture Drug Batches in Preparation for Planned Clinical Trials CHASKA, Minn. and BOSTON, Ma...

CHASKA, Minn., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:  LFCR ) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that the company will participate at DCAT Week 20...

2026-01-14 01:05:00 ET The following segment was excerpted from the Laughing Water Capital Q4 2025 Letter ... Read the full article on Seeking Alpha For further details see: Lifecore Biomedical: Wins Should Blow Previous 'New Business' Es...

2026-01-01 08:50:51 ET It is easy to look at a chart that has run up ~25% YTD and assume the opportunity has passed. In many cases you would be right, but Lifecore Biomedical ( LFCR ) is currently exiting an extended period of punishment by the market that has obscured its true valu...

LG Display Co Ltd AMERICAN DEPOSITORY SHARES (LPL) is expected to report $0.06 for Q3 2025 NovaBridge Biosciences (NBP) is expected to report $-0.06 for Q3 2025 New Fortress Energy Inc. (NFE) is expected to report $-0.89 for Q3 2025 Cambium Networks Corporation (CMBM) is expected to r...

2025-12-29 05:15:03 ET KeyBanc analyst issues SECTOR WEIGHT recommendation for LFCR on December 29, 2025 10:02AM ET. The previous analyst recommendation was Sector Weight. LFCR was trading at $8.3 at issue of the analyst recommendation. The overall analyst consensus : BU...

2025-12-27 11:00:00 ET Get ahead of the market by subscribing to Seeking Alpha's Wall Street Week Ahead, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings re...

HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS PR Newswire Shareholders should contact the firm immediately as there may be limited time to enforce your rights.   NEW YORK , Dec. 24, 2025 /PRNewswire/ -...